跳至主要内容
临床试验/NCT07025616
NCT07025616尚未招募不适用

Effectiveness of Buteyko Breathing Exercise in Children With Uncontrolled Asthma: A Single Blind, Randomized Controlled Trial

Ivan Sofian Wibowo1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2025年6月最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
74
试验地点
1
主要终点
Asthma control

研究概览

简要总结

This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 7-17 years
  • Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score > 1)
  • Receive bronchodilator therapy, either oral or inhaler from a pediatrician.
  • Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form.
  • Can understand instructions.

排除标准

  • Have received Buteyko breathing exercises or other breathing exercises.
  • Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.
  • Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.
  • Have contraindications for spirometry examination

研究组 & 干预措施

Buteyko

Experimental

Buteyko breathing exercise plus pharmacological treatment

干预措施: Buteyko (Behavioral)

Buteyko

Experimental

Buteyko breathing exercise plus pharmacological treatment

干预措施: Asthma reliever and controller (Drug)

Control

Active Comparator

Pharmacological treatment

干预措施: Asthma reliever and controller (Drug)

结局指标

主要结局

Asthma control

时间窗: At enrollment and end of fourth-week

Level of asthma control measured by Asthma Control Questionnaire (ACQ) - Indonesian version. Minimum value 0, maximum value 6. Higher score means worse outcome.

次要结局

  • Asthma Quality of Life(At enrollment and end of fourth-week)
  • Bronchodilator use(At end of fourth-week)
  • FEV1(At enrollment and end of fourth-week)
  • FVC(At enrollment and end of fourth-week)
  • FEV1/FVC(At enrollment and end of fourth-week)
  • PEFR(At enrollment and end of fourth-week)
  • Control Pause(At enrollment and end of fourth-week)

研究者

发起方
Ivan Sofian Wibowo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ivan Sofian Wibowo

dr.

Indonesia University

研究点 (1)

Loading locations...

相似试验